Evidence map›Paper›PMID 41407464›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2025

[The role and molecular mechanism of transcription factor EB and its target genes in multiple myeloma treatment with bortezomib].

R J Zhang, Z L Wang, X M Shi, S Y Zhang, W Wang, M S Ma, C Li, C H Gu, Z H Zhang

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

R J ZhangDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China Hebei Key Laboratory of Panvascular Diseases, Chengde 067000, China.
Z L WangDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
X M ShiDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
S Y ZhangDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
W WangDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
M S MaDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
C LiDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
C H GuDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China.
Z H ZhangDepartment of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde 067000, China Hebei Key Laboratory of Panvascular Diseases, Chengde 067000, China.

Funding

Hebei Provincial Government Funded Program for Outstanding Clinical Medical Talents ZF2025251
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsMultiple MyelomaAutophagyBortezomibCell Line, TumorHedgehog ProteinsHumansPatched-1 ReceptorRNA, Small InterferingSignal TransductionZinc Finger Protein GLI1Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsBortezomibGLI1 protein, humanHedgehog ProteinsPatched-1 ReceptorPTCH1 protein, humanRNA, Small InterferingTFEB protein, humanZinc Finger Protein GLI1AutophagyBortezomibGene expression regulationMultiple myelomaTranscription factors

Identifiers

PMID41407464
PMCPMC12708955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.